David Turkaly analyst

Currently out of the existing stock ratings of David Turkaly, 190 are a BUY (92.23%), 15 are a HOLD (7.28%), 1 are a SELL (0.49%).

David Turkaly

Work Performance Price Targets & Ratings Chart

Analyst David Turkaly, carries an average stock price target met ratio of 36.15% that have a potential upside of 27.51% achieved within 248 days.

David Turkaly’s has documented 394 price targets and ratings displayed on 22 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on AXGN, Axogen at 30-Jul-2026.

Wall Street Analyst David Turkaly

Analyst best performing recommendations are on NVTR (NUVECTRA).
The best stock recommendation documented was for LNTH (LANTHEUS HOLDINGS) at 2/24/2026. The price target of $78 was fulfilled within 7 days with a profit of $4.39 (5.96%) receiving and performance score of 8.52.

Average potential price target upside

APYX Apyx Medical AXGN Axogen HAE Haemonetics IART Integra LifeSciences Holdings KIDS Orthopediatrics Corp NVRO Nevro Corp SRGA Surgalign Holdings STE STERIS plc STIM Neuronetics TFX Teleflex ZBH Zimmer Biomet Holdings SIBN Si-Bone FNA Paragon 28 ICAD icad inc NVTR Nuvectra TELA Tela Bio GMED Globus Medical LNTH Lantheus Holdings AVNS Avanos Medical ENOV Enovis Corp OFIX Orthofix Medical SYK Stryker

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 21-Mar-2023

$8

$3.5 (77.78%)

Buy Since 08-Dec-2022

$2.5

$-1.46 (-36.87%)

$2.5

Show more analysts

Please expand the browser size to see the chart

Which stock is David Turkaly is most bullish on?

Potential upside of $14.05 has been obtained for LNTH (LANTHEUS HOLDINGS)

Which stock is David Turkaly is most reserved on?

Potential downside of $1.98 has been obtained for TELA (TELA BIO)

What Year was the first public recommendation made by David Turkaly?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?